Reinilde Heyrman

Directeur Technique/Scientifique/R&D chez MEDPACE HOLDINGS, INC.

65 ans

Health Technology

Consumer Services

Commercial Services

Profil

Dr. Reinilde Heyrman, MD, is a Chief Medical Officer at Medpace Holdings, Inc. Dr. Heyrman was previously employed as a Secretary, Chief Clinical Development Officer & VP by Bellerophon Therapeutics, Inc. and a Chief Clinical Development Officer by Ikaria, Inc. She received her doctorate degree from the University of Antwerp.

Postes actifs de Reinilde Heyrman

Sociétés	Poste	Début
MEDPACE HOLDINGS, INC.	Directeur Technique/Scientifique/R&D	01/09/2017

Tous les postes actifs de Reinilde Heyrman

Anciens postes connus de Reinilde Heyrman

Sociétés	Poste	Fin
IKARIA, INC.	Corporate Officer/Principal	-
BELLEROPHON THERAPEUTICS, INC.	Directeur Technique/Scientifique/R&D	-

Voir l'expérience en détail de Reinilde Heyrman

Formation de Reinilde Heyrman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Reinilde Heyrman

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Ikaria, Inc. Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics	Health Technology
Bellerophon Therapeutics, Inc. Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases	Health Technology
University of Antwerp University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Medpace Holdings, Inc. Medpace Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a a clinical contract research organization company which provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries	Commercial Services